Selected Cell
Cell:
Value:
InvestigationInformation
StudyInformation
AssayInformation
AssayConditions
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| #Template info | |||||||||
| #TemplateVersion | LEI-MIHCSME_userTemplate_v3 | version 3 is updated version including recommendations by users, plus ISA and REMBI compliant. | |||||||
| #DateTemplateGenerated | Jan-20-2023 | ||||||||
| #CreatedBy | RH | ||||||||
| Annotation_groups | Key | Value | Comments_User | Description_Examples_Values | |||||
| DataOwner | First Name | Matthijs | First Name | ||||||
| DataOwner | Middle Name(s) | Middle Name(s) if any | |||||||
| DataOwner | Last Name | Vlasveld | Last Name | ||||||
| DataOwner | User name | vlasveldmp | Institutional user name | ||||||
| DataOwner | Institute | LACDR | Institute level, eg. Universiteit Leiden, Faculty of Science, Institute of Biology | ||||||
| DataOwner | E-Mail Address | m.p.vlasveld@lacdr.leidenuniv.nl | Institution email address | ||||||
| DataOwner | ORCID investigator | orcid id as url, eg. https://orcid.org/0000-0002-3704-3675 | |||||||
| DataCollaborator | ORCID Data Collaborator | ORCID is of collaborator with experimental, collection or analysis part of this investigation | |||||||
| DataCollaborator | ORCID Data Collaborator | ORCID is of collaborator with experimental, collection or analysis part of this investigation | |||||||
| InvestigationInformation | Project ID | IMI2 eTRANSAFE | EU/NWO/consortium ID – Examples: EuTOX | ||||||
| InvestigationInformation | Investigation Title | Is integrated stress response related expression of CHOP predictive for DILI | High level concept to link related studies. Could be the main hypothesis/question you want to investigate as part of your research. Could be a chapter/thesis of your work. | ||||||
| InvestigationInformation | Investigation internal ID | iMV01 | Corresponding internal ID for your investigation. | ||||||
| InvestigationInformation | Investigation description | Development of High-throughput screening pipeline for Drug Safety Assessment | Short description for your investigation. | ||||||
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| # comments: | |||||||||
| # | |||||||||
| # | |||||||||
| # | |||||||||
| Annotation_groups | Key | Value | Comments_User | Description_Examples_Values | |||||
| Study | Study Title | The integrated stress response-related expression of CHOP due to mitochondrial toxicity is predictive for drug-induced liver injury liability. | Manuscript/chapter/publication/paragraph title describing purpose or intention for one or multiple assays (screens/experiments) | ||||||
| Study | Study internal ID | sMV03 | Study ID, linked to ELN or lab journal | ||||||
| Study | Study Description | High throughput screen of FDA approved drugs on HepG2 CHOP-GFP reproter, followed by downstream hit analysis | Description of study with additional unstructured information about this study possibly not covered elsewhere in this template. | ||||||
| Study | Study Key Words | drug-induced liver injury, high-throughput screening, CHOP, mitochondrial toxicity, integrated stress response | List of key words associated with your study (EFO-terms). Examples: FDA approved drugs, Kinase inhibitors, DNA damage response, Unfolded protein response, Oxidative stress response, Inflammatory signaling, chemical similarity | ||||||
| Biosample | Biosample Taxon | NCBITAXON:9606 | NCBI-taxon id, human = NCBITAXON:9606; | ||||||
| Biosample | Biosample description | Genetically modified human hepatoma HepG2 cell line using bacterial artificial cloning | Description of biosample genotype; Additional unstructured information about organisms used in this experiment. | ||||||
| Biosample | Biosample Organism | Human | Which organism is your cell lines or tissue from. Examples: Human or mouse | ||||||
| Biosample | Number of cell lines used | 1 | In case multiple cell lines are used indicate here | ||||||
| Library | Library File Name | FDA_lib_v2.xlsx | Library file info | ||||||
| Library | Library File Format | xlsx | Library file info | ||||||
| Library | Library Type | Compound library | Library file info | ||||||
| Library | Library Manufacturer | Selleck Chem | Library file info | ||||||
| Library | Library Version | 2018-08-01T0:0:0+0000 | Library file info | ||||||
| Library | Library Experimental Conditions | NA | Any experimental conditions some cells were grown under as part of the study enter the information here e.g. different environmental stress conditions, or mutant background compared to wild type. | ||||||
| Library | Quality Control Description | NA | A brief description of the kind of quality control measures that were taken. | ||||||
| Protocols | HCS library protocol | SOP_FDA-KI_library_primaryScreen_v1.3.docx | Url/doi protocols.io or ELN associated url. At least SOP/protocol filename | ||||||
| Protocols | growth protocol | SOP_FDA-KI_library_primaryScreen_v1.3.docx | Url/doi protocols.io or ELN associated url. At least SOP/protocol filename | ||||||
| Protocols | treatment protocol | SOP_FDA-KI_library_primaryScreen_v1.3.docx | Url/doi protocols.io or ELN associated url. At least SOP/protocol filename | ||||||
| Protocols | HCS data analysis protocol | SOP_FDA-KI_library_primaryScreen_DataAnalysis_v1.1.docx | Url/doi protocols.io or ELN associated url. At least SOP/protocol filename | ||||||
| Plate | Plate type | uclear | Example: uclear | ||||||
| Plate | Plate type Manufacturer | Greiner Bio-One | Example: Greiner Bio-One | ||||||
| Plate | Plate type Catalog number | 781081 | Example:781081 | ||||||
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
| # comments: | |||||||||
| # | |||||||||
| # | |||||||||
| # | |||||||||
| Annotation_groups | Key | Value | Comments_User | Description_Examples_Values | |||||
| Assay | Assay Title | High-throughput screen of HepG2 CHOP-GFP reporter | Screen name | ||||||
| Assay | Assay internal ID | aMV01 | Experimental ID, e.g. aMV-010, linked to ELN or labjournal | ||||||
| Assay | Assay Description | High-throughput screen of HepG2 CHOP-GFP reporter using FDA approved drugs and kinase inhibitors | Description of screen plus additional unstructured information about screen not covered elsewhere. Stages of HCS: either primary screen, secondary screen or validation screen. EFO terms | ||||||
| Assay | Assay number of biological replicates | 3 | Total number of biol. Repl. | ||||||
| Assay | Number of plates | 24 | Total number of plates, n-plates | ||||||
| Assay | Assay Technology Type | confocal microscopy | Imaging method, Fbbi terms. | ||||||
| Assay | Assay Type | high content screen of cells in treated with a compound library | List of options: sub types of HCS e.g. Gene Knock down, RNAi, compount, EFO terms | ||||||
| Assay | Assay External URL | NA | ELN or any other external url link to this screen. | ||||||
| Assay | Assay data URL | https://omeroweb.services.universiteitleiden.nl/webclient/?show=screen-1460 | OMERO url link to this screen. | ||||||
| AssayComponent | Imaging protocol | SOP_FDAKIScreen.docx | Url to protocols.io or protocols in ELN, at least protocol file name or free text description of imaging protocol | ||||||
| AssayComponent | Sample preparation protocol | SOP_FDAKIScreen.docx | Sample preparation method (Formaldahude (PFA) fixed tissue, Live cells, unfixed tissue). FBbi terms | ||||||
| Biosample | Cell lines storage location | N2 tank 4th flour | Storage location according to Database used or at least location e.g. Example -150 liquid N2 tank 4th floor GE4.xx | ||||||
| Biosample | Cell lines clone number | 16 | Storage location DB info | ||||||
| Biosample | Cell lines Passage number | 18 | Passage number of your cells. In case different passage number is used for the replicates, please indicate it in Comment_users. | ||||||
| ImageData | Image number of pixelsX | 512 | Indicate number of pixels in x in images | ||||||
| ImageData | Image number of pixelsY | 512 | Indicate number of pixels in y in images | ||||||
| ImageData | Image number of z-stacks | 1 | Indicate number z stacks in image, single image is z=1 | ||||||
| ImageData | Image number of channels | 2 | Indicate number of channels in your image, single channel image c=1, including your TD channel | ||||||
| ImageData | Image number of timepoints | 1 | Indicate number of time point(s) in your image | ||||||
| ImageData | Image sites per well | 2 | Number of fields, numeric value | ||||||
| ImageAcquisition | Microscope id | Nikon 3 | Url to micrometa app file link or other url describing your microscope. At least Microscope name. | ||||||
| Specimen | Channel Transmission id | NA | Channel id is dependent on different machines, first or last. If No transmission is acquired state NA | ||||||
| Specimen | Channel 1 visualization method | Hoechst 33342 | Visualization method (example: Hoechst staining ) | ||||||
| Specimen | Channel 1 entity | DNA | Entity visualized (example: DNA ) | ||||||
| Specimen | Channel 1 label | Nuclei | Label used for entity (example:Nuclei) Best practice to use similar label as your CP-pipeline | ||||||
| Specimen | Channel 1 id | 1 | sequential id of channel order in your image | ||||||
| Specimen | Channel 2 visualization method | fluorescent protein tag | Visualization method (example: GFP ) | ||||||
| Specimen | Channel 2 entity | DDIT3 | Entity visualized (example: MAP1LC3B ) | ||||||
| Specimen | Channel 2 label | CHOP-GFP | Label used for entity (example:GFP-LC3) Best practice to use similar label as your CP-pipeline | ||||||
| Specimen | Channel 2 id | 2 | sequential id of channel order in your image | ||||||
| Specimen | Channel 3 visualization method | propidium iodide | Visualization method (example: PI staining ) | ||||||
| Specimen | Channel 3 entity | DNA | Entity visualized (example: Death cell DNA ) | ||||||
| Specimen | Channel 3 label | PI | Label used for entity (example:PI) Best practice to use similar label as your CP-pipeline | ||||||
| Specimen | Channel 3 id | 3 | sequential id of channel order in your image | ||||||
| Specimen | Channel 4 visualization method | Visualization method (example: Apoptotic marker Annexin V staining ) | |||||||
| Specimen | Channel 4 entity | Entity visualized (example: Apoptotic cells ) | |||||||
| Specimen | Channel 4 label | Label used for entity (example:Annexin-V) Best practice to use similar label as your CP-pipeline | |||||||
| Specimen | Channel 4 id | sequential id of channel order in your image |
A
B
C
D
E
F
G
H
I
J
5101
5102
5103
5104
5105
5106
5107
5108
5109
5110
5111
5112
5113
5114
5115
5116
5117
5118
5119
5120
5121
5122
5123
5124
5125
5126
5127
5128
5129
5130
5131
5132
5133
5134
5135
5136
5137
5138
5139
5140
5141
5142
5143
5144
5145
5146
5147
5148
5149
5150
5151
5152
5153
5154
5155
5156
5157
5158
5159
5160
5161
5162
5163
5164
5165
5166
5167
5168
5169
5170
5171
5172
5173
5174
5175
5176
5177
5178
5179
5180
5181
5182
5183
5184
5185
5186
5187
5188
5189
5190
5191
5192
5193
5194
5195
5196
5197
5198
5199
5200
| HepG2-CHOP-GFP | B03 | S7177 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | M08 | S7214 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | K23 | S7289 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | H06 | S7332 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | B11 | S7461 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | I14 | S2247 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D04 | S2617 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | C04 | S2636 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D20 | S2679 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L21 | S2692 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L16 | S2720 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | F03 | S2742 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | H11 | S2755 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | I22 | S2774 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J18 | S2807 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J14 | S2842 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | C16 | S2882 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | F15 | S2911 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | O20 | S4901 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | N08 | S7016 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | N21 | S7060 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | B18 | S7104 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L13 | S7167 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D08 | S7207 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | M18 | S7257 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | K11 | S7319 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D15 | S7422 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | O09 | S2391 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | I03 | S2625 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | E23 | S2670 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L22 | S2683 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J17 | S2700 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | I16 | S2729 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | O16 | S2747 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J03 | S2767 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | N18 | S2791 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | G22 | S2816 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L09 | S2864 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | K16 | S2897 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | B05 | S2928 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | G05 | S6005 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D14 | S7039 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | O08 | S7091 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D23 | S7136 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | K05 | S7194 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | F18 | S7215 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | M19 | S7291 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | C05 | S7356 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | N05 | S7482 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | G06 | S8024 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | E10 | S8040 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | M20 | S8031 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J12 | S8044 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | E15 | S8032 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | B20 | S8050 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | O17 | S8036 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | B14 | S8057 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | F11 | S8058 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | F20 | S8078 | 50 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | G20 | Tunicamycin_c1a | 0.15 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | D11 | Tunicamycin_c2a | 0.34 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | O18 | Tunicamycin_c3a | 0.77 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | I13 | Tunicamycin_c4a | 1.73 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | N23 | Tunicamycin_c5a | 3.9 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | K12 | Tunicamycin_c6a | 8.77 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | C02 | Tunicamycin_c7a | 19.73 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | K21 | Tunicamycin_c8a | 44.4 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | C21 | Tunicamycin_c1b | 0.15 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | K22 | Tunicamycin_c2b | 0.34 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | M11 | Tunicamycin_c3b | 0.77 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | M15 | Tunicamycin_c4b | 1.73 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | M22 | Tunicamycin_c5b | 3.9 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | F10 | Tunicamycin_c6b | 8.77 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | E12 | Tunicamycin_c7b | 19.73 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | E19 | Tunicamycin_c8b | 44.4 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | L14 | Mitomycin_1 | 150 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | G17 | Mitomycin_2 | 150 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | G15 | Mitomycin_3 | 150 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | G14 | Mitomycin_4 | 150 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | F21 | DMSO_1 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | K20 | DMSO_2 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | O10 | DMSO_3 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | H19 | DMSO_4 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | M12 | DMSO_5 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | J15 | DMSO_6 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | C22 | DMSO_7 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | B06 | DMSO_8 | 0.5 | uM | 20190222-p8-KIN2 | 24 | Rep3 | Control | |
| HepG2-CHOP-GFP | E11 | Empty_1 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | N17 | Empty_2 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | D18 | Empty_3 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J07 | Empty_4 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L04 | Empty_5 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | H20 | Empty_6 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | B13 | Empty_7 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | O03 | Empty_8 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | F13 | Empty_9 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | L05 | Empty_10 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | N02 | Empty_11 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | J13 | Empty_12 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI | |
| HepG2-CHOP-GFP | K18 | Empty_13 | 0.001 | uM | 20190222-p8-KIN2 | 24 | Rep3 | KI |
